Acamprosate Calcium Tablets
Last Updated: December 16, 2015
Products Affected - Description
All presentations are currently available
Reason for the Shortage
- Glenmark Pharmaceuticals could not provide a reason for the shortage.
- Mylan could not provide a reason for the shortage.
- Actavis discontinued Campral tablets in 2014.
Acamprosate calcium oral tablet, Glenmark
333 mg tablets, 180 count (NDC 68462-0435-18)
333 mg, bottle, 180 count (NDC 00378-6333-80)
333 mg, unit-dose 50 count (NDC 51079-0241-06)
Estimated Resupply Dates
All presentations are currently available.
- Memantine Hydrochloride — Resolved
December 16 and 1, October 29, September 3, July 9, June 2, May 21 and 6, March 30, February 27, January 30, 2015, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.